Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
458 6 |
Ultima descărcare din IBN: 2021-11-24 14:23 |
Căutarea după subiecte similare conform CZU |
616.98:578.834.1-078 (1) |
Инфекционные заболевания. Инфекционные лихорадки (587) |
Вирусология (446) |
SM ISO690:2012 SPÎNU, Constantin, CEBOTARI, Svetlana, SAJIN, Octavian, SPÎNU, Igor, DONOS, Ala, VOLNEANSCHI, Ana, GOSTEV, Igor, DOPIRA, Iurie. Evaluarea prezenței anticorpilor anti SARS-CoV- 2 la donatorii de plasmă convalescentă cu scopul de a argumenta utilizarea lor în tratamentul COVID-19. In: One Health and Risk Management, 2021, nr. 2(2), pp. 58-64. ISSN 2587-3458. DOI: https://doi.org/10.38045/ohrm.2021.2.08 |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
One Health and Risk Management | ||
Numărul 2(2) / 2021 / ISSN 2587-3458 /ISSNe 2587-3466 | ||
|
||
DOI:https://doi.org/10.38045/ohrm.2021.2.08 | ||
CZU: 616.98:578.834.1-078 | ||
Pag. 58-64 | ||
Descarcă PDF | ||
Rezumat | ||
Introduction. Currently, COVID-19 treatment includes several options, including the use of convalescent plasma. Therefore, the presence of anti-SARS-CoV-2 in blood donors after the clinical recovery of COVID-19, depending on their place of residence, age and the clinical manifestation of the disease is of scientific-practical interest. Material and methods. A total of 119 donors among patients were examined, namely males aged 18-60 years, having a past history of COVID-19 disease, being confirmed by PCR and treated, showing a negative PCR-based test result, which was performed at least 14 days after clinical recovery. The presence/absence of anti-SARS-CoV-2 was assessed by enzyme-linked immunosorbent assay. Results. The obtained data showed that 87.4% of plasma donors responded to COVID-19 infection by anti-SARS-CoV-2 IgG expression, being predominantly found in the 26-35 age group. Most donors experienced mild and medium clinical forms. It is important to note that all severe clinical manifestations of the infection were followed by formation of antiSARS-CoV-2 IgG. Urban living environment was predominantly found in convalescent donors (75.0%), which indicates that they are better informed by medical institutions. Conclusions. The study shows that male blood donors aged 18-60 years, subsequently cured and being positive to anti-SARS-CoV-2 IgG can serve as a source of fresh plasma used for the treatment of COVID-19 patients. |
||
Cuvinte-cheie COVID-19 treatment, plasma donors, anti SARSCoV2, IgG class antibodies, tratamentul COVID-19, plasma donatorilor, anti SARS-CoV-2, anticorpi IgG |
||
|